IQ-AI Limited (LON:IQAI)
London
· Delayed Price · Currency is GBP · Price in GBX 0.8450
0.00 (0.00%)
Apr 25, 2025, 4:35 PM BST
IQ-AI Revenue
In the year 2024, IQ-AI had annual revenue of 750.11K GBP with 23.09% growth. IQ-AI had revenue of 444.25K in the half year ending June 30, 2024, with 73.80% growth.
Revenue
750.11K
Revenue Growth
+23.09%
P/S Ratio
2.78
Revenue / Employee
107.16K
Employees
7
Market Cap
2.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 750.11K | 140.72K | 23.09% |
| Dec 31, 2023 | 609.39K | 73.50K | 13.72% |
| Dec 31, 2022 | 535.89K | 14.82K | 2.84% |
| Dec 31, 2021 | 521.07K | 265.76K | 104.09% |
| Dec 31, 2020 | 255.31K | -17.55K | -6.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |